April 26th, 2022
Amedisys announces the promotion of Nick Muscato to Chief Strategy Officer, effective immediately.
“I am thrilled to announce the promotion of Nick Muscato to Chief Strategy Officer,” stated Chris Gerard, President and CEO of Amedisys. “He brings a wealth of expertise to the team and has been key to the creation and implementation of Amedisys’ strategy over the past seven years. His innovative mind and unique ability to forecast the future of our industry will be invaluable to Amedisys’ upward trajectory.”
In his leadership roles at Amedisys, most recently Senior Vice President of Finance, Muscato has been responsible for leading Investor Relations (IR) and creating an IR strategy that has resulted in strong relationships with our analysts, lenders and shareholders, while enhancing the Company’s IR reputation. He’s also helped to lead corporate strategy, the treasury function and data and analytics team, along with playing a pivotal role in strategic investments as part of Amedisys’ long-term strategy such as Contessa Health, which allows Amedisys to provide high-acuity care in the home, ConnectRN and Medalogix. Muscato also serves on the Board of Directors for ConnectRN and Medalogix.
“Working for a Company that allows more seniors to heal and age where they most want to be – in the home – has been incredibly rewarding, and I look forward to advancing this cause as part of the executive leadership team,” stated Chief Strategy Officer Nick Muscato. “I am honored to help Amedisys fulfill its vision and extremely excited about all of the opportunity we have in front of us.”